Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$3.5M
Filings
29
Firms Hired
1
Active Period
2019–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicaid VBPs for Patients Act
2024 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $90,000 · Firm income: —
Matched citations: HR 2666
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $90,000 · Firm income: —
Matched citations: HR 7384
Medicaid VBPs for Patients Act
2024 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $90,000 · Firm income: —
Matched citations: HR 2666
Creating Hope Reauthorization Act of 2024
2024 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $90,000 · Firm income: —
Matched citations: HR 7384
Medicaid VBPs for Patients Act
2024 · first_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $210,000 · Firm income: —
Matched citations: HR 2666
Creating Hope Reauthorization Act of 2024
2024 · first_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act HR 7384 - Creating Hope Reauthorization Act of 2024 Safe Labor Draft Legislation
Client expense: $210,000 · Firm income: —
Matched citations: HR 7384
Medicaid VBPs for Patients Act
2023 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Client expense: $140,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Client expense: $140,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input on potential gene therapy demo for sickle cell disease beneficiaries of Medicaid
Client expense: $140,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · third_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Client expense: $150,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act
Client expense: $80,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · third_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P)
Client expense: $120,000 · Firm income: —
Matched citations: HR 2666
Medicaid VBPs for Patients Act
2023 · second_quarter · Firm: BLUEBIRD BIO, INC.
HR 2666 - MVP Act
Client expense: $60,000 · Firm income: —
Matched citations: HR 2666
Newborn Screening Saves Lives Reauthorization Act of 2019
2020 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Client expense: $180,000 · Firm income: —
Matched citations: H.R. 2507
Prescription Drug Pricing Reduction Act of 2019
2020 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Client expense: $180,000 · Firm income: —
Matched citations: S. 2543
Newborn Screening Saves Lives Reauthorization Act of 2019
2020 · third_quarter · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Client expense: $200,000 · Firm income: —
Matched citations: H.R. 2507
Prescription Drug Pricing Reduction Act of 2019
2020 · third_quarter · Firm: BLUEBIRD BIO, INC.
H.R. 2507 Newborn Screening Saves Lives Reauthorization Act of 2019 S. 2543 Prescription Drug Pricing Reduction Act of 2019 Proposed Rule - Establishing Minimum Standards in Medicaid State Drug Utilization Review and Supporting Value-based Purchasing for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability Requirements [CMS-2482-P]
Client expense: $200,000 · Firm income: —
Matched citations: S. 2543
Newborn Screening Saves Lives Reauthorization Act of 2019
2020 · second_quarter · Firm: BLUEBIRD BIO, INC.
Value-based payment and drug pricing in general. S. 2543, Prescription Drug Pricing Reduction Act. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Client expense: $180,000 · Firm income: —
Matched citations: H.R. 2507
Prescription Drug Pricing Reduction Act of 2019
2020 · second_quarter · Firm: BLUEBIRD BIO, INC.
Value-based payment and drug pricing in general. S. 2543, Prescription Drug Pricing Reduction Act. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019.
Client expense: $180,000 · Firm income: —
Matched citations: S. 2543
Prescription Drug Pricing Reduction Act of 2019
2020 · second_quarter · Firm: BLUEBIRD BIO, INC.
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019, Value based payment.
Client expense: $180,000 · Firm income: —
Matched citations: S. 2543
Newborn Screening Saves Lives Reauthorization Act of 2019
2020 · first_quarter · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 2507
Elijah E. Cummings Lower Drug Costs Now Act
2020 · first_quarter · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Client expense: $220,000 · Firm income: —
Matched citations: H.R. 3
Prescription Drug Pricing Reduction Act of 2019
2020 · first_quarter · Firm: BLUEBIRD BIO, INC.
Gene therapies, drug pricing, and Bluebird Bio specifically. S. 2543 Prescription Drug Pricing Reduction Act of 2019
Client expense: $220,000 · Firm income: —
Matched citations: S. 2543
Prescription Drug Pricing Reduction Act of 2019
2020 · first_quarter · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act; value-based payment. Value-based drug pricing and drug pricing in general. H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3 Elijah E. Cummings Lower Drug Costs Act.
Client expense: $220,000 · Firm income: —
Matched citations: S. 2543
Newborn Screening Saves Lives Reauthorization Act of 2019
2019 · fourth_quarter · Firm: BLUEBIRD BIO, INC.
S. 2543, Prescription Drug Pricing Reduction Act: issues related to value-based payment. Issues related to value-based drug pricing and drug pricing in general. Issues related to H.R. 2507, Newborn Screening Saves Lives Reauthorization Act of 2019. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act: issues related to value-based payment
Client expense: $280,000 · Firm income: —
Matched citations: H.R. 2507
Source: Senate LDA